In 2003, Sean George, director of business segments for cell biology, made the cover of Invitrogen’s annual report after moving into his position from Molecular Probes, which Invitrogen acquired that August. Today, George has a new position as vice president of diagnostic tools and solutions for Invitrogen and will be responsible for guiding the integration of the firm’s technology with that of Dynal, which Invitrogen this week said it plans to acquire for $386 million in a transaction that is expected to close in April (see article, page 1).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.